News For Placebo


New Oral GLP-1 Application Submitted to FDA - Semaglutide - Diabetes In Control

New Oral GLP-1 Application Submitted to FDA - Semaglutide  Diabetes In Control

Novo Nordisk announced the official submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for oral tablet semaglutide.

Google 3/23/2019 12:41:21 AM

FDA issues complete response letter for sotagliflozin - Healio

FDA issues complete response letter for sotagliflozin  Healio

The FDA on Friday issued a complete response letter regarding a new drug application for oral sotagliflozin, a first-in-class dual SGLT1 and SGLT2 inhibitor for ...

Google 3/23/2019 12:37:10 AM

Scientist hopes CBD product will help kids with intellectual disabilities - Q13 News Seattle

Scientist hopes CBD product will help kids with intellectual disabilities  Q13 News Seattle

SEATTLE - You've heard of CBD, an extract derived from cannabis; the popularity and the touted benefits continue to spread. Now a local scientist is embarking ...

Google 3/22/2019 11:17:00 PM

Conatus drug misses goal, hitting NASH stocks - BioPharma Dive

Conatus drug misses goal, hitting NASH stocks  BioPharma Dive

Conatus Pharmaceuticals on Thursday disclosed its lead liver disease drug emricasan missed its primary goal in a Phase 2b study of patients with non-alcoholic ...

Google 3/22/2019 9:23:47 PM

Novel dermatology drugs approved in 2018 - Dermatology Times

Novel dermatology drugs approved in 2018  Dermatology Times

In many ways, 2018 was a banner year for new novel drug approvals with 59 drugs approved by the FDA's Center for Drug Evaluation and Research (CDER).

Google 3/22/2019 7:03:09 PM

Niraparib extends time without symptoms in ovarian cancer - Medical Xpress

Niraparib extends time without symptoms in ovarian cancer  Medical Xpress

(HealthDay)—Women with recurrent ovarian cancer who receive the poly ADP ribose polymerase (PARP) inhibitor niraparib as maintenance therapy after ...

Google 3/22/2019 7:00:25 PM

Intranasal RSV Vaccine Candidate Generated Durable Immune Response - PrecisionVaccinations

Intranasal RSV Vaccine Candidate Generated Durable Immune Response  PrecisionVaccinations

An intranasal subunit vaccine (SynGEM) that introduces the respiratory syncytial virus (RSV), has demonstrated efficacy in actuating lasting immune responses ...

Google 3/22/2019 6:37:17 PM

Another promising Alzheimer’s drug trial ends in failure: ‘This one hurts’ - Q13 News Seattle

Another promising Alzheimer’s drug trial ends in failure: ‘This one hurts’  Q13 News Seattle

It's another devastating blow in the search for a treatment for patients living with Alzheimer's disease.

Google 3/22/2019 6:24:00 PM

 1 2 3 4 5  ...